Hungary Pharmaceuticals and Healthcare Report Q4 2013:Life Sciences Market Research Reports

Life Sciences Market Research Reports

Refresh your vocabulary. Learn a new word everyday by subscribing to Word of the Day. A great tool if you're studying for the GRE, GMAT or LSAT, or simply want to enhance your lexicon. From our sponsors

Hungary Pharmaceuticals and Healthcare Report Q4 2013 Aug 21st 2013, 00:00, by rnrmahesh BMI View: Hungary’s deteriorating outlook for pharmaceutical companies has contributed to its continued placement on the Special 301 Priority Watch List in the Pharmaceutical Research and Manufacturers of America (PhRMA)’s 2013 Annual Report to the US Trade Representative (USTR). Since the implementation of the Hungarian Pharma-economic Law (XCVIII/2006) and the Széll Kálmán Plan, pharmaceutical expenditure has been drastically cut in Hungary in an effort to balance the state’s budget. Such draconian measures have reduced drug expenditure in Hungary to 2006 levels and this decline is expected to continue in 2013 and beyond, impacting all stakeholders in the pharmaceutical market. Headline … Order / Buy a copy of this report @ http://www.rnrmarketresearch.com/contacts/purchase?rname=111949. Complete report details with Table of Contents and more @ http://www.rnrmarketresearch.com/hungary-pharmaceuticals-and-healthcare-report-q4-2013-market-report.html.

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions